The Food and Drug Administration said it approved Novartis' drug Afinitor to treat some of the tumors caused by a rare genetic disorder called tuberous sclerosis.
Pharmaceutical giant Pfizer Inc. said that revenue in the third quarter jumped 39 percent due to its acquisition of fellow drugmaker Wyeth, but hefty charges related to that $68 billion purchase dragged its profit down 70 percent.
Rubicon Genomics reported data demonstrating that its PicoPlex kits currently marketed for the analysis of single cells for research and diagnostic applications also provide important advantages for genetic and epigenetic profiling using next-generation sequencing.
Accelrys, Inc. announced the release of version 3.3 of the Isentris data access, analysis, and decision support system. Isentris 3.3 enables scientists to display, manipulate, and compare spectral, chromatographic, and XY graphical data.
Nycomed announced that it is significantly expanding its presence in China through the acquisition of a majority stake in Guangdong Techpool Bio-Pharma Co., Ltd., a fast-growing Chinese bio-pharmaceutical company based in Guangdong.
Medical supplies distributor McKesson Corp. said it will pay $560 million in cash to acquire US Oncology, a company that provides drugs and services to 500 cancer centers across the U.S.
Scientists from the UK and Australia have seen the human immune system's assassin – a protein called perforin – in action for the first time.
Researchers have reached an early, but important, milestone in the quest to grow replacement livers in the lab. They have used human liver cells to engineer miniature livers that function—at least in a laboratory setting—like human livers.
Gilead Sciences, Inc. announced new data from the open-label phase of two pivotal Phase 3 clinical trials evaluating the four-year efficacy of Viread (tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B virus infection.
Abbott and Enanta Pharmaceuticals announced positive results from a Phase 2 study of ABT-450/r, an investigational, oral protease inhibitor being developed for the treatment of hepatitis C (HCV) infection.
Forest Laboratories, Inc. announced that Teflaro was approved by the U.S. Food and Drug Administration for the treatment of community-acquired bacterial pneumonia.
Fifty years after the pill, another birth control revolution may be on the horizon: free contraception for women in the U.S., thanks to the new health care law.
Recent improvements to spectrophotometers help keep them indispensible in the lab.
Forston Labs’ LabNavigator is the most powerful and intuitive hand-held analytical meter for the lab or plant. The GPS function allows user to streamline reporting and records time/date stamps with location for each data point collected.
The new UPLSAPO 30x and UPLSAPO 60x silicone oil objectives can markedly improve optical performance for live cell confocal, widefield fluorescence, multiphoton, differential interference contrast (DIC) and other applications.